4
Changes in Ownership
RESMED INC Filed Acc 0001127602-25-008958
Chief Executive Officer sold 8,009 shares at $229.20 ($1,835,692)
- Chief Executive Officer acquired 8,009 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,009 | $101.64 | $814,035 | 463,481 | D |
| 2025-03-07 | Sale : show line 2 in the form 10b5-1 | −8,009 | $229.20 | $1,835,692 | 455,472 | D |
| Open-market sales · 8,009 sh · avg $229.20 · $1,835,692 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-07 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −8,009 | 64,074 | D |
Loading xslF345X05/form4.xml…